FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer-Reference-Cited by-同舟云学术

FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer

Published:2013-10 Issue:5 Volume:22 Page:691-697
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Koolen Bas B.,Pengel Kenneth E.,Wesseling Jelle,Vogel Wouter V.,Vrancken Peeters Marie-Jeanne T.F.D.,Vincent Andrew D.,Gilhuijs Kenneth G.A.,Rodenhuis Sjoerd,Rutgers Emiel J.Th.,Valdés Olmos Renato A.

Funder

CTMM, the Center for Translational and Molecular Medicine

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference36 articles.

1. Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer;Kaufmann;Ann Surg Oncol,2012

2. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer;Fisher;J Clin Oncol,1998

3. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27;Rastogi;J Clin Oncol,2008

4. Neoadjuvant chemotherapy for operable breast cancer;Mieog;Br J Surg,2007

5. The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy;Straver;Ann Surg Oncol,2010

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of [18F]FDG PET/CT in patients with no special type breast cancer: Literature review and comparison between guidelines;The Breast;2024-09

2. Metabolic adaptation towards glycolysis supports resistance to neoadjuvant chemotherapy in early triple negative breast cancers;Breast Cancer Research;2024-02-19

3. The Current and Future Roles of Precision Oncology in Advanced Breast Cancer;Journal of Nuclear Medicine;2024-02-01

4. Breast cancer: treatment response assessment with FDG-PET/CT in the neoadjuvant and in the metastatic setting;Clinical and Translational Imaging;2023-07-27

5. Association between the systemic immune-inflammation index and the efficacy of neoadjuvant chemotherapy, prognosis in HER2 positive breast cancer—a retrospective cohort study;Gland Surgery;2023-05